| Literature DB >> 34459825 |
Mengya Wang1, Bianca N Mason2, Levi P Sowers3, Adisa Kuburas4, Brandon J Rea3, Andrew F Russo5.
Abstract
Migraine is a complex neurological disorder characterized by headache and sensory abnormalities, such as hypersensitivity to light, observed as photophobia. Whilst it is impossible to confirm that a mouse is experiencing migraine, light aversion can be used as a behavioral surrogate for the migraine symptom of photophobia. To test for light aversion, we utilize the light/dark assay to measure the time mice freely choose to spend in either a light or dark environment. The assay has been refined by introducing two critical modifications: pre-exposures to the chamber prior to running the test procedure and adjustable chamber lighting, permitting the use of a range of light intensities from 55 lux to 27,000 lux. Because the choice to spend more time in the dark is also indicative of anxiety, we also utilize a light-independent anxiety test, the open field assay, to distinguish anxiety from light-aversive behavior. Here, we describe a modified test paradigm for the light/dark and open field assays. The application of these assays is described for intraperitoneal injection of calcitonin gene-related peptide (CGRP) in two mouse strains and for optogenetic brain stimulation studies.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34459825 PMCID: PMC8428768 DOI: 10.3791/62839
Source DB: PubMed Journal: J Vis Exp ISSN: 1940-087X Impact factor: 1.424